(Q80114138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

M Lassila

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

K Fukami

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

K Jandeleit-Dahm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

T Semple

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

P Carmeliet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

M E Cooper

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

6 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1315-1326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17415547%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-007-0652-x

28 December 2019

exact match

0 references

cites work

PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction

1 reference

12 December 2020

Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells and stimulates the conversion of pro-MMP-2 to MMP-2: role of MMP-2 in factor Xa-induced DNA synthesis and matrix invasion

1 reference

12 December 2020

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

1 reference

12 December 2020

Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy

1 reference

12 December 2020

Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice

1 reference

12 December 2020

Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells

1 reference

12 December 2020

Plasminogen activator inhibitor type 1: the two faces of the same coin

1 reference

12 December 2020

Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy

1 reference

12 December 2020

Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis

1 reference

12 December 2020

Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease

1 reference

12 December 2020

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

1 reference

12 December 2020

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

1 reference

12 December 2020

Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis

1 reference

12 December 2020

High glucose reduces generation of plasmin activity by mesangial cells

1 reference

12 December 2020

Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

1 reference

12 December 2020

Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice

1 reference

12 December 2020

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization

1 reference

12 December 2020

A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis

1 reference

12 December 2020

Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.

1 reference

12 December 2020

Expression of transforming growth factor-beta isoforms in human glomerular diseases

1 reference

12 December 2020

Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury

1 reference

12 December 2020

Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction.

1 reference

12 December 2020

Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies

1 reference

12 December 2020

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

1 reference

12 December 2020

Plasmin is not protective in experimental renal interstitial fibrosis

1 reference

12 December 2020

Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation

1 reference

12 December 2020

Quantification of matrix metalloproteinases in tissue samples

1 reference

12 December 2020

Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice.

1 reference

12 December 2020

Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1.

1 reference

12 December 2020

Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice.

1 reference

12 December 2020

Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta

1 reference

12 December 2020

PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria

1 reference

12 December 2020

Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice.

1 reference

12 December 2020

Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy

1 reference

12 December 2020

Glomerular matrix accumulation is linked to inhibition of the plasmin protease system

1 reference

12 December 2020

Mouse models of diabetic nephropathy

1 reference

12 December 2020

Model of robust induction of glomerulosclerosis in mice: importance of genetic background.

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney

1 reference

12 December 2020

Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice

1 reference

12 December 2020

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice

1 reference

12 December 2020

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy

1 reference

12 December 2020

Plasminogen activator inhibitor-1 and the kidney

1 reference

12 December 2020

Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study

1 reference

12 December 2020

Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients

1 reference

12 December 2020

Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis

1 reference

12 December 2020

Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy

1 reference

12 December 2020

Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models

1 reference

12 December 2020